1 Collaborative Drug Discovery – Acerand Case Study q Acerand Therapeutics Uses CDD Vault Across Two Sites and Multiple CROs in Search for New Drug Candidates Situation Acerand Therapeutics, founded by industry veterans with Lilly Asian Ventures (LAV), is an innovative biotech company focusing on the discovery and development of novel best-in- class and/or first-in-class drug candidates for clinical development. The company has operations both in Shanghai, China as well as Indianapolis, U.S., to reflect its overall global strategy and business intents. Founded in June 2020, the company’s chemists and biologists are focused on creating new drugs for oncology and autoimmu

Join for free to read